This course consists of four modules. You’ll earn four hours of continuing education credit upon completion.

Sedation dentists treat patients with a variety of diseases. Some of those diseases, like asthma, are commonplace and well diagnosed. Others, like sleep apnea, are common but go largely undiagnosed. Still, others like osteonecrosis of the jaw appear as adverse reactions caused by drugs used for bone cancers and osteoporosis.

Treating patients with disease or symptoms of disease requires a keen understanding of how their body is likely to respond to sedatives. It also requires knowing how the drugs they’re taking interact with sedatives. In this recertification course, Drs. Anthony Feck and Leslie Fang share patient selection best practices. They also reveal new treatment options for patients who want sedation dentistry but suffer from compromised health.

Asthma and COPD

According to the CDC, more than 25 million Americans have asthma and 11 million Americans have COPD (millions more may be undiagnosed). At present, neither disease has a cure; treatment relies on management through medication. In this module, Dr. Feck provides an overview of the respiratory system and symptoms that indicate respiratory stress.

In addition, you’ll learn:

• Why experience can hurt established sedation dentists
• The difference between hypercarbic and hypoxic drive responses
• The best diagnostic tests for assessing respiratory function

… and more.

Sleep Apnea

Identifying patients with sleep apnea, the partial or complete obstruction of the airway, should be a priority for sedation dentists. Why? Because of the enormous strain it puts on a patient’s health. In this module, Dr. Feck describes sleep apnea: its symptoms, its forms, and its prevalence.  

In addition, you’ll learn:

• Why sleep apnea drives oral parafunctional habits
• How to use a pulse oximeter to replicate the effects of sleep apnea
• Why you should use short-acting sedatives with apnea patients

… and more.

Peri-Implant Mucositis and Peri-Implantitis

The same pathogens that cause periodontal disease cause peri-implantitis. Yet, the former is well known, affecting up to 65 million Americans, while the latter is known only by dentists and those with failing implants. In this module, Drs. Feck and Fang discuss effective protocol for treating two site-specific diseases that may affect patients with implants.

• Why “snot clots” are essential for treating infected gums
• How to prepare and apply platelet-rich plasma
• Why the “golden protocol” is never wrong, but isn’t always the best option

… and more.

Medication Related Osteonecrosis of the Jaw

Medication related osteonecrosis of the jaw (MRONJ) is an adverse reaction to drug therapy. It’s difficult to treat. Both anti-cancer drugs (angiogenesis inhibitors) and bone-strengthening drugs (bisphosphonates) have been associated with MRONJ cases. In this module, Drs. Fang and Feck look at the clinical implications of MRONJ for dentists.

In addition, you’ll learn:

• Why cancer survivors may be vulnerable to invasive dentistry

• The three cancer patients most likely to be using anti-angiogenics
• How to treat a patient before he or she begins IV bisphosphonate therapy

… and more.

Keep your oral sedation permit current while gleaning insight from two doctors with more than 75 years of combined experience.

Buy this course today and access it for one full year.

All sales are final.